Correlation Between Lyell Immunopharma and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Eliem Therapeutics, you can compare the effects of market volatilities on Lyell Immunopharma and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Eliem Therapeutics.
Diversification Opportunities for Lyell Immunopharma and Eliem Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyell and Eliem is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Eliem Therapeutics
Given the investment horizon of 90 days Lyell Immunopharma is expected to under-perform the Eliem Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyell Immunopharma is 1.07 times less risky than Eliem Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Eliem Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 253.00 in Eliem Therapeutics on August 30, 2024 and sell it today you would earn a total of 51.00 from holding Eliem Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Lyell Immunopharma vs. Eliem Therapeutics
Performance |
| Timeline |
| Lyell Immunopharma |
| Eliem Therapeutics |
Lyell Immunopharma and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyell Immunopharma and Eliem Therapeutics
The main advantage of trading using opposite Lyell Immunopharma and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |